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Sulfonamides are synthetic chemotherapeutic agents that work as competitive inhibitors of the di-12 hydro-pteroate synthase (DHPS) enzyme, encoded by the folP gene. Resistance to sulfonamides is 13 widespread in the clinical setting and predominantly mediated by plasmid-and integron-borne sul1-3 14 genes encoding mutant DHPS enzymes that do not bind sulfonamides. In spite of their clinical 15 importance, the genetic origin of sul1-3 genes remains unknown. Here we analyze sul genes and their 16 genetic neighborhoods to uncover sul signature elements that enable the elucidation of their genetic 17 origin. We identify a protein sequence Sul motif associated with sul-encoded proteins, as well as 18 consistent association of a phosphoglucosamine mutase gene (glmM) with the sul2 gene. We identify 19
chromosomal folP genes bearing these genetic markers in two bacterial families: the Rhodobiaceae 20 and the Leptospiraceae. Bayesian phylogenetic inference of FolP/Sul and GlmM protein sequences 21 clearly establishes that sul1-2 and sul3 genes originated as a mobilization of folP genes present in, 22
respectively, the Rhodobiaceae and the Leptospiraceae, and indicate that the Rhodobiaceae folP gene 23 was transferred from the Leptospiraceae. Analysis of %GC content in folP/sul gene sequences 24 supports the phylogenetic inference results and indicates that the emergence of the Sul motif in 25 chromosomally-encoded FolP proteins is ancient and considerably predates the clinical introduction 26 of sulfonamides. In vitro assays reveal that both the Rhodobiaceae and the Leptospiraceae, but not 27 other related chromosomally-encoded FolP proteins confer resistance in a sulfonamide-sensitive 28
Escherichia coli background, indicating that the Sul motif is associated with sulfonamide resistance. 29 Given the absence of any known natural sulfonamides targeting DHPS, these results provide a novel 30 perspective on the emergence of resistance to synthetic chemotherapeutic agents, whereby 31 preexisting resistant variants in the vast bacterial pangenome may be rapidly selected for and 32 mobilized upon the clinical introduction of novel chemotherapeuticals. Antibiotic resistance is a pressing problem in modern healthcare [1, 2] . Bacterial cells present several 37 mechanisms to cope with exposure to antibiotics or chemotherapeutic agents, which may be acquired 38 through mutation or, most frequently, via lateral gene transfer on mobile genetic elements [3] . These 39 mechanisms include modification of the antimicrobial target, degradation or chemical modification 40 of the antimicrobial molecule, targeted reduction of antimicrobial uptake, active export of the 41 antimicrobial through efflux pumps and use of alternate pathways and enzymes [3] . 42
It is widely accepted that many antibiotic resistance genes present today in pathogenic bacteria 43 originated from homologs evolved over eons in either the microbes that naturally produce the 44 antibiotics or their natural competitors [4] . When coupled with the high plasticity of bacterial 45 genomes and their co-existence with a large variety of genetic mobile elements, the availability of a 46 readily evolved pool of antibiotic resistance genes set the stage for the rapid proliferation of multi-47 resistant strains in the clinical setting shortly after the commercial introduction of antibiotics [4] . In 48 contrast, the origins of resistance against chemotherapeutic agents are harder to pinpoint. Since these 49
were designed in vitro, it seems unlikely that a large pool of genes conferring resistance to 50 chemotherapeutic agents existed before their introduction. After their discovery in the 1960's, 51
resistance to quinolones was initially rare and limited to chromosomal mutations in DNA gyrase, 52
topoisomerase IV or efflux pumps [5] . However, in the early 2000's plasmid-borne qnr genes were 53 first detected and spread rapidly to clinical pathogens. Qnr is a member of the pentapeptide repeat 54 family and was shown to confer resistance by binding to DNA gyrase and limiting the effect of 55 quinolone drugs. The origin of plasmid-borne qnr genes has been traced to environmental homologs 56 and these are thought to have derived from genes originally targeting antibiotics, such as microcin 57 B17 [6] . 58
Aryl sulfonamides are synthetic antibacterial compounds presenting a similar structure to para-amino 59 benzoic acid (PABA), and containing a sulfonamide group linked to an aromatic group. [20] . 83
The sul3 gene was characterized in the Escherichia coli conjugative plasmid pVP440. It was shown 84 to be flanked by two copies of the insertion element IS15Δ/26 and to be widespread in E. coli isolates 85 from pigs in Switzerland [21] . Recently, a sul4 gene was identified in a systematic prospection of 86 class 1 integron-borne genes in Indian river sediments, but this sul variant has not yet been detected 87 in clinical isolates. Genomic context analyses revealed that the sul4 gene had been recently mobilized 88 and phylogenetic inference pinpointed its putative origin as part of the folate synthesis cluster in the 89
Chloroflexi phylum [22] . 90
Despite the importance of sulfonamides in human and animal therapy, the putative origin of the three 91
sul genes that account for the vast majority of reported clinical resistance to sulfonamide remains to 92 be elucidated. In this work we leverage comparative genomics, phylogenetic analysis and in vitro 93 determination of minimal inhibitory concentrations (MIC) of sulfamethoxazole to unravel the origin 94 of the sul1, sul2 and sul3 genes. Our analysis indicates that chromosomally-encoded folP genes 95 conferring resistance to sulfonamide originated in members of the Leptospiraceae family and were 96 transferred to the Alphaproteobacteria Rhodobiaceae family more than 500 million years ago. These 97 isolated sources of chromosomally-encoded sulfonamide-resistant DHPS were mobilized 98 independently following the commercial introduction of sulfonamides, leading to the broadly 99 disseminated sul1, sul2 and sul3 resistance genes. 
Identification of putative chromosomal origins for sul1-3 genes 169
To identify putative chromosomal homologs of sul1-3 genes, we performed a multiple sequence 170 alignment including any protein sequences with at most 99% similarity to those encoded by sul1-3 171 genes reported in the literature and by chromosomal folP genes from a representative of each 172 bacterial order. Inspection of the resulting alignment ( Figure 1A ; Supplementary material 3) revealed 173 the presence of a two-amino acid insertion in proteins encoded by sul1-3 genes that is not present in 174 those encoded by sul4 or the analyzed chromosomal folP genes. This two-amino acid insertion is 175 located in a conserved region of the FolP protein (residues R171-N211 of the E. coli FolP protein 176
[WP_000764731]) that presents other signature changes in sul-encoded proteins with respect to 177 chromosomally-encoded FolP proteins ( Figure 1AB ; Supplementary Alphaproteobacteria lineages ( Figure 1C ). Analysis of the folP genetic surroundings in complete 199 genomes of the Spirochaetes and the Alphaproteobacteria shows clear differences between the genes 200 coding for the identified Rhodobiaceae and Leptospiraceae FolP * proteins harboring the two-amino 201 acid insertion pattern and those without it ( Figure 1C ). The Leptospiraceae show a conserved 202 arrangement with folP * flanked by a peptidoglycan-associated lipoprotein and a tetratricopeptide 203
repeat-containing domain protein, whereas in most other Spirochaetes folP is flanked by a 1-deoxy-204 D-xylulose-5-phosphate synthase and a diadenylate cyclase. In contrast, the Alphaproteobacteria 205 yield several distinct syntenic regions for folP. In the Rhodobiaceae, folP * is flanked by genes coding 206
for either a FtsH-family metallopeptidase or a TetR-family transcriptional repressor and the 207 phosphoglucosamine mutase glmM. In the Rhodobacterales, folP is flanked by a dihydroneopterin 208 aldolase and glmM, but in the Rhizobiales it is flanked by a Zn-dependent proteoase and the 209 dihydroneopterin aldolase. This last arrangement, in which the dihydroneopterin aldolase is followed 210 by a 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase is also part of the 211 genetic surroundings of folP in most Actinobacteria ( Figure 1C ). 212
Phylogenetic analysis of sul/folP and glmM genes 213
The presence of a signature two-amino acid insertion characteristic of sul gene products in 214 chromosomally-encoded FolP * proteins and the identification of a genetic environment for sul2 genes 215 that is conserved in multiple bacterial genomes suggested that it might be possible to pinpoint the 216 evolutionary origin of sul genes. To further investigate this possibility, we performed a rigorous 217 phylogenetic analysis of FolP/Sul protein sequences. We sampled a representative genome of all 218 bacterial orders with complete genome assemblies, of each bacterial family for the Proteobacteria and 219 all available complete genomes for clades of interest (Rhodobiaceae, Spirochaetes and Chlamydiae), 220
and we identified chromosomally-encoded FolP homologs in each of these genomes using BLASTP 221
with the E. coli FolP protein as a query. We used a distance tree generated with CLUSTALW to 222 identify and discard a set of protein sequences from duplicated folP genes in the Actinobacteria 223
(Supplementary material 7), and we performed multiple sequence alignment and Bayesian phylogenetic 224 reconstruction of the remaining FolP/Sul sequences with T-COFFEE and MrBayes (Supplementary 225 material 8).
226
The resulting tree ( Figure 2 ) provides strong support for the hypothesis that sul1-3 genes originated in 227
the Rhodobiaceae and Leptospiraceae families. In particular, the topology inferred by MrBayes 228
suggests that the Leptospiraceae folP * gene gave rise to both sul3 and the folP * gene encountered in 229
the Rhodobiaceae, most likely through a lateral gene transfer event in an ancestor of this 230
Alphaproteobacteria family. According to the reconstructed FolP phylogeny, the Rhodobiaceae folP * 231
gene was subsequently mobilized as sul2, and later evolved into the integron-borne sul1 gene [44] . 232
The fact that the Leptospiraceae FolP * sequences branch independently of other Spirochaetes 233 sequences and immediately after the Chlamydiae suggests that the Leptospiraceae folP * gene might 234
have originated as a result of lateral gene transfer event from the Chlamydiae, and that it 235 subsequently incorporated the signature two-amino acid insert present in sul-encoded DHPS proteins. 236
The existence of a genetic environment for sul2 genes conserved in bacterial chromosomes provides 237 the means to independently assess the likelihood of the evolutionary scenario inferred from the FolP 238 phylogeny. Using the same sampling methods utilized for sul/folP protein products, we collected 239 protein sequences for phosphoglucosamine mutase (GlmM) homologs and performed Bayesian 240 phylogenetic inference on the aligned N-terminal regions. The resulting GlmM tree ( Figure 3 ) 241 provides further support for a Rhodobiaceae origin of the sul2 gene, with the sul2-associated GlmM 242 sequences branching with the Rhodobiaceae GlmM protein sequences deep within an otherwise 243 monophyletic Alphaproteobacteria clade. Taken together, the consistent branching with the 244
Rhodobiaceae of the protein sequences encoded by both sul2 and its accompanying glmM gene 245 fragment firmly establish this Alphaproteobacteria family as the chromosomal origin for the sul2 246 gene. The phylogenetic evidence thus indicates that the sul2 gene was excised with the N-terminal 247 fragment of the glmM gene during the mobilization event that led to their incorporation into plasmid 248 vectors. Given that the folP-glmM arrangement is only seen in the Proteobacteria, this also excludes 249 the possibility that the sul2 gene was mobilized directly from a Leptospiraceae background, where 250 the folP gene presents an unrelated, yet conserved, genomic environment ( Figure 1C ). 251
Analysis of sul/folP and glmM gene sequences 252
The phylogenetic analysis of FolP and GlmM sequences puts forward an evolutionary scenario 253
wherein the Leptospiraceae folP * was transferred to the members of the Rhodobiaceae family before 254 being mobilized independently into the sul3-and sul1/2-harboring mobile genetic elements reported 255 in sulfonamide-resistant clinical isolates. To further investigate this hypothesis, we undertook a 256 systematic analysis of folP and glmM coding sequences. We compiled folP gene sequences for all the 257 FolP proteins included in the phylogenetic analysis (Figure 2 ), as well as any sul gene sequences with 258 less than 90% identity to those reported in the literature and any chromosomal folP * genes encoding a 259 DHPS with the signature Sul motif ( Figure 1A) for which there were at least 1 Mbp of whole genome 260
shotgun sequence data (Supplementary material 9). We computed the overall and codon-position %GC 261 content on both the folP/sul coding sequences and all the available coding sequences in their 262 respective genome assembly (Supplementary material 10). The %GC content data ( Figure 4A these data provide strong support for an independent mobilization of sul1/2 and sul3 genes from, 268 respectively, Rhodobiaceae and Leptospiraceae chromosomal backgrounds. 269
The independent mobilization of sul1/2 and sul3 is underpinned by a preceding lateral gene transfer 270 of folP * from the Leptospiraceae into a Rhodobiaceae ancestor. In this context, the substantial 271 divergence in %GC content between the chromosomal folP * genes of both clades indicates a long 272 process of amelioration. In fact, statistical analysis of the differences in codon position %GC content 273
between folP genes and all available coding sequences in their respective genomes shows that 274
Leptospiraceae and Rhodobiaceae folP * genes encoding proteins with the Sul motif cannot be 275 distinguished from other folP genes (one-sided Mann-Whitney U-test p > 0.05 for GC1, GC2 and 276 GC3) ( Figure 4B Mann-Whitney U-test p > 0.05), indicating that the glmM gene fragment associated with sul genes 284 was not transferred from a mobile element into the Rhodobiaceae (Supplementary material 11). 285
Sulfonamide resistance of chromosomal folP genes 286
Phylogenetic and sequence analysis results indicate that chromosomal folP * genes encoding proteins 287 with the signature Sul motif were independently mobilized into the sul1-3-harboring mobile elements 288 found in sulfonamide-resistant clinical isolates, but they do not address whether the presence of this 289 motif is associated with sulfonamide resistance. of the chromosomal origins of sul1-3 genes 308
The introduction of sulfonamides in the late 1930's was soon followed by the emergence of 309 resistance due primarily to mutations in chromosomal folP genes [7] . In this context, the most 310 plausible hypothesis for the origin of mobilized folP homologs (the sul genes) conferring resistance 311 to sulfonamides might appear to involve the uptake by mobile elements of chromosomal folP genes 312 that had undergone selection for sulfonamide resistance upon its introduction as a systemic 313 chemotherapeutic agent. Our analysis, however, indicates that the sul1-3 genes responsible for 314 sulfonamide resistance in clinical isolates did not arise from recently mutated chromosomal folP 315 genes. Instead, our results imply that sul1-3 originated via the independent mobilization of a 316
chromosomal folP * gene that had been horizontally transferred at least once between divergent 317 bacterial clades ( Figure 5 ). This evolutionary scenario is supported by several complementary lines of 318 evidence. The identification of a conserved region incorporating a signature two-amino acid insertion 319 shared by all reported sul1-3 gene instances and members of the two posited donor families 320 (Rhodobiaceae and Leptospiraceae) ( Figure 1AB ) provides strong support for a common origin of 321 these sequences. This result is substantiated by the solidly supported branching of Sul1-3 protein 322 sequences with members of the Rhodobiaceae and Leptospiraceae families in the reconstructed 323
FolP/Sul molecular phylogeny (Figure 2 ). Importantly, the trimmed multiple sequence alignment used 324
for FolP/Sul Bayesian phylogenetic inference (Supplementary material 8) does not incorporate the two-325 amino acid insertion of the Sul motif, indicating that the joint branching of Sul1-3 sequences with 326 chromosomally-encoded Rhodobiaceae and Leptospiraceae FolP proteins is based on sequence 327 similarity beyond this insertion and its immediate vicinity ( Figure 1AB ). 328
The presence of glmM gene fragments downstream of sul2 genes in sul2 isolates (Supplementary 329 material 1) and the presence of a similar arrangement in the Proteobacteria ( Figure 1C ) provide an 330 independent means for assessing the origin of sul2 genes. Phylogenetic inference results for the N-331
terminal region of GlmM (Figure 3) are consistent with those observed for FolP ( Figure 2 ), and clearly 332 define a last common ancestor between the Rhodobiaceae and sul2-associated glmM genes. Analysis 333 of synonymous and non-synonymous substitutions among Rhodobiaceae glmM genes suggests that 334 the glmM gene has undergone similar patterns of selection regardless of its association to folP genes 335 encoding the signature two-amino acid insertion (Supplementary material 11). Since the glmM gene 336 fragment associated to sul2 genes is likely to be non-functional and subject to genetic drift, the 337 absence of diverging substitution patterns between the N-and C-terminal regions of Rhodobiaceae 338
glmM sequences indicates that the glmM and sul2 genes were transferred from the Rhodobiaceae to 339 sul2-harboring vectors, and not vice versa. Lastly, given that gene loss is much more likely than gain 340 [45] , the absence of glmM fragments in sul1 isolates supports in turn the notion that sul1 derived 341 from sul2. This is consistent with the branching pattern observed in the FolP/Sul tree (Figure 2 ), 342
which defines a scenario of independent mobilization of sul3 from the Leptospiraceae and sul2 from 343
the Rhodobiaceae, with the subsequent uptake of sul1 by class 1 integrons. 344
The analysis of folP codon %GC content provides further evidence for the evolutionary scenario 345 outlined above ( Figure 5 ). The %GC content of sul3 genes is very similar to that of Leptospiraceae 346 folP sequences, whereas those of sul2 and sul1 closely match Rhodobiaceae folP genes. Given that more than thirty years elapsed between the introduction of sulfonamides and the detection of sul-348 harboring vectors [7], it is reasonable to assume that sul genes were mobilized from chromosomal 349 origins some period of time after the discovery of sulfonamide. Sequence evolution models indicate 350 that, even under fast-evolution scenarios, amelioration from sul3 to sul1/2 %GC content (or vice 351 versa) is not feasible in such a short time [32] . In fact, forward simulations suggest that an 352 evolutionary span of at least 476 million years is required to achieve such rates of amelioration. This 353 is congruent with the transfer of folP * from the Leptospiraceae to the Rhodobiaceae taking place 354
after the inferred diversification of the Alphaproteobacteria into its constituent families some 1,500 355 million years ago [34] . This timeline is also consistent with the analysis of %GC content, which 356
shows evidence of complete amelioration in Rhodobiaceae folP * genes ( Figure 4B ). Such an ancestral 357 gene transfer event is also congruent with the lack of canonical telltale signs of lateral gene transfer 358 in either chromosomal background, such as the presence of transposase/integrase genes in the 359 immediate vicinity of folP * , with the substantial diversity of genomic surroundings observed for the 360 folP gene in the Alphaproteobacteria ( Figure 1C ), and with the overlap in habitats between both 361 bacterial families [46, 47] . Taken together, these results provide strong support for the hypothesis that 362 the sul1-3 genes present in clinical isolates were mobilized from chromosomal Leptospiraceae and 363
Rhodobiaceae backgrounds following the introduction of sulfonamides in the late 1930's. 364
Prevalence of sulfonamide resistance in ancestral bacteria 365
Several independent lines of evidence converge towards an evolutionary scenario in which sul1-3 366 genes from clinical isolates derive from ancestral chromosomal mutations in the folP * gene of the 367
Leptospiraceae and the Rhodobiaceae (Figure 5 ). This raises several important questions regarding 368 the nature and impact of such chromosomal mutations, the selective pressures underpinning their 369 origin and transfer in ancient bacteria, and their subsequent mobilization into the resistance sul genes 370 found in clinical isolates. Minimum inhibitory concentration (MIC) assays confirm that both the 371
Leptospiraceae and the Rhodobiaceae folP * genes provide a level of resistance to sulfamethoxazole 372 comparable to that provided by sul2 gene in an E. coli background, whereas complementation with a 373
Rhodobacteraceae folP does not confer resistance (Table 1 ). These data are in agreement with 374 previous reporting of sulfonamide resistance in multiple L. interrogans strains [48-50], and suggest 375 that the observed resistance was likely due to mutations in the Leptospiraceae chromosomal folP * 376 gene rather than to the presence of plasmid-borne sul genes. 377
In contrast with the Leptospiraceae and the Rhodobiaceae folP * genes, the chromosomal folKP gene 378 of the Chlamydiae, which encodes a DHPS lacking the Sul motif, does not confer resistance to 379 sulfamethoxazole (Table 1 ). This is in agreement with abundant reports of sulfonamide susceptibility 380
in several Chlamydia species [51-54]. Since the Chlamydiae folKP gene is the most closely related 381 chromosomal folP gene to the cluster encompassing the sul genes and the Leptospiraceae and the 382
Rhodobiaceae folP * (Figure 2 ), the lack of resistance in Chlamydiae folKP genes strongly suggests 383 that changes in the region encompassing the Sul motif may be responsible for the observed 384
resistance. This region is located in a connector loop within the N-terminal 'pole' of the eight-385 stranded α/β barrel of DHPS, which is involved in sulfonamide recognition [39, 40] . The two-amino 386 acid insertion might hence result in decreased affinity for sulfonamide by locally disrupting folding 387 as has been proposed previously for similar insertions [55] . 388
The emergence and maintenance of a sulfonamide-resistant folP * gene in the Leptospiraceae and its 389 subsequent transfer to the Rhodobiaceae suggests that it might convey some selective advantage, but 390 the advent of mutations providing significant resistance and their subsequent spread could also have 391 been fortuitous. The appearance of sulfonamide-resistance mutations in chromosomal folP genes has 392 been amply documented [7, 13] , and these were in fact the primary drivers of sulfonamide 
Mobilization of ancestral resistance reservoirs 409
The phylogenetic inference and genomic analysis results reported in this work uphold an 410 evolutionary scenario wherein chromosomally-encoded sulfonamide resistant folP variants were 411 independently mobilized from Leptospiraceae and Rhodobiaceae backgrounds following the clinical 412 introduction of synthetic aryl sulfonamides, giving rise to the sul1/2 and sul3 genes routinely 413 detected in clinical isolates ( Figure 5 ). The rapid mobilization and dissemination of genes conferring 414 resistance to antibiotic and chemotherapeutic agents upon the clinical or agricultural use of these 415 compounds has been amply documented [4, 61] . Mobilization and spread may be mediated by 416 plasmids encoding transposons and integrons, as well as integrative and conjugative elements, mobile 417 pathogenicity islands and bacteriophages, but the common tenet is that sustained exposure of 418 bacterial populations to antibiotics or chemotherapeutic agents induces a strong selective pressure to 419 elicit the mobilization of resistance determinants [61] . 420
Together with penicillin and tetracycline, sulfonamides have been the antibacterial agents most 421 frequently used at sub-therapeutic levels in livestock production [62], and it has been reported that 422 sulfonamides have higher mobility, low removal efficiency and deeper environmental penetration 423 than most other antibacterial agents [63] . The widespread and intensive use of sulfonamides in 424 agriculture, aquaculture and animal husbandry since the mid 1960's, and their persistence in soil, 425 sediments and subterranean aquatic communities where Leptospiraceae and Rhodobiaceae abound, 426
provides an ample window of opportunity for the mobilization of chromosomally-encoded folP * 427 genes within these bacterial communities and the subsequent transfer of these mobile resistance 428 determinants to other bacteria. 429
Recent mobilization from a Chloroflexi chromosomal folP background has been postulated as the 430 likely origin of the sul4 gene [22] , and this result is in agreement with the phylogenetic analysis 431 reported here (Figure 2 ). In the case of the chromosomal folP * identified here and their mobilization 432
into sul-harboring resistance vectors, several sources of evidence provide additional support for the 433 mobilization of chromosomal folP genes. For instance, phylogenetic evidence ( Figure 2) that antibiotic resistance predates the use of antibiotics by humans, and that it is widely distributed 454 across the bacterial pangenome. In a few isolated cases, resistance determinants for synthetic 455 chemotherapeutic agents that predate or have rapidly arisen upon human use has been documented, 456
but their existence can be attributed to cross-resistance to naturally-occurring antibiotics (e.g. 457
microcin B17 for quinolones [6] , sisomicin for amikacin [69] ). The identification in this work of 458 ancient chromosomal mutations in folP conferring resistance to sulfonamide as the likely origins of 459 the sul1-3 genes present in sulfonamide-resistant clinical isolates puts forward an alternative 460 scenario. Given the absence of known naturally occurring aryl sulfonamides targeting DHPS, our 461 results suggest that resistance to novel synthetic chemotherapeutic agents may be already available in 462 the vast microbial pangenome, and that its mobilization and global dissemination can take place in a 463 very short amount of time upon the clinical introduction of novel chemotherapeutic compounds. 464
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